Have your own idea? Try our Stock Screener
In the last week, the Life Sciences industry is flat overall, with Medpace Holdings standing out by going down 9.1%. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 18% per annum.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 31 Aug 2024 | US$746.6b | US$141.8b | US$8.5b | 37.8x | 87.9x | 5.3x |
Mon, 29 Jul 2024 | US$732.9b | US$141.0b | US$12.6b | 37.3x | 58.3x | 5.2x |
Wed, 26 Jun 2024 | US$696.3b | US$141.3b | US$12.2b | 38.2x | 57.2x | 4.9x |
Fri, 24 May 2024 | US$735.1b | US$141.5b | US$12.4b | 38.7x | 59.2x | 5.2x |
Sun, 21 Apr 2024 | US$681.6b | US$142.0b | US$12.8b | 40.8x | 53.3x | 4.8x |
Tue, 19 Mar 2024 | US$742.5b | US$142.1b | US$12.8b | 44.3x | 57.8x | 5.2x |
Thu, 15 Feb 2024 | US$697.5b | US$142.2b | US$12.8b | 43x | 54.3x | 4.9x |
Sat, 13 Jan 2024 | US$684.9b | US$153.9b | US$14.2b | 35.4x | 48.3x | 4.5x |
Mon, 11 Dec 2023 | US$644.8b | US$153.7b | US$14.0b | 35.2x | 46x | 4.2x |
Wed, 08 Nov 2023 | US$590.2b | US$153.9b | US$11.0b | 30.9x | 53.6x | 3.8x |
Fri, 06 Oct 2023 | US$642.5b | US$154.6b | US$11.2b | 33x | 57.4x | 4.2x |
Sun, 03 Sep 2023 | US$735.8b | US$154.6b | US$11.2b | 33.1x | 65.7x | 4.8x |
Tue, 01 Aug 2023 | US$727.5b | US$154.7b | US$11.6b | 31.1x | 62.6x | 4.7x |
Thu, 29 Jun 2023 | US$680.9b | US$152.4b | US$12.5b | 29.5x | 54.4x | 4.5x |
Sat, 27 May 2023 | US$677.4b | US$152.2b | US$12.5b | 27.7x | 54.2x | 4.5x |
Mon, 24 Apr 2023 | US$728.5b | US$154.6b | US$10.8b | 29.9x | 67.4x | 4.7x |
Wed, 22 Mar 2023 | US$711.8b | US$154.5b | US$10.8b | 26.7x | 65.8x | 4.6x |
Fri, 17 Feb 2023 | US$744.7b | US$154.2b | US$8.6b | 31.6x | 86.6x | 4.8x |
Sun, 15 Jan 2023 | US$761.4b | US$155.3b | US$8.5b | 30.6x | 89.3x | 4.9x |
Tue, 13 Dec 2022 | US$772.2b | US$155.1b | US$8.8b | 29x | 88x | 5x |
Thu, 10 Nov 2022 | US$701.4b | US$154.8b | US$8.9b | 26.2x | 79x | 4.5x |
Sat, 08 Oct 2022 | US$723.9b | US$152.5b | US$17.0b | 23.8x | 42.6x | 4.7x |
Mon, 05 Sep 2022 | US$753.3b | US$152.3b | US$17.3b | 28.7x | 43.5x | 4.9x |
Wed, 03 Aug 2022 | US$823.0b | US$151.6b | US$18.2b | 33.5x | 45.3x | 5.4x |
Fri, 01 Jul 2022 | US$721.6b | US$148.1b | US$20.1b | 30.3x | 35.9x | 4.9x |
Sun, 29 May 2022 | US$773.5b | US$148.1b | US$20.1b | 31.8x | 38.5x | 5.2x |
Tue, 26 Apr 2022 | US$804.5b | US$147.3b | US$25.4b | 31.8x | 31.7x | 5.5x |
Thu, 24 Mar 2022 | US$846.7b | US$145.0b | US$25.3b | 35.2x | 33.5x | 5.8x |
Sat, 19 Feb 2022 | US$825.6b | US$144.8b | US$25.4b | 37.9x | 32.6x | 5.7x |
Mon, 17 Jan 2022 | US$878.1b | US$138.0b | US$27.3b | 39.9x | 32.1x | 6.4x |
Wed, 15 Dec 2021 | US$960.7b | US$138.0b | US$27.3b | 43.2x | 35.2x | 7x |
Fri, 12 Nov 2021 | US$963.1b | US$137.8b | US$27.1b | 46.1x | 35.5x | 7x |
Sun, 10 Oct 2021 | US$709.1b | US$105.9b | US$18.6b | 46x | 38.2x | 6.7x |
Tue, 07 Sep 2021 | US$754.5b | US$106.0b | US$18.6b | 51.2x | 40.6x | 7.1x |
40.6x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.056% | |
Healthcare | 0.90% | |
Life Sciences | 0.73% | |
Clinical Research and Equipment | 0.73% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TMO Thermo Fisher Scientific | US$615.07 | 1.5% +US$3.4b | 10.4% | PE37.8x | |
STVN Stevanato Group | US$21.88 | 17.6% +US$895.0m | -34.3% | PE44.1x | |
WST West Pharmaceutical Services | US$313.63 | 3.6% +US$787.1m | -23.1% | PE43.3x | |
BIO Bio-Rad Laboratories | US$337.32 | 7.1% +US$623.7m | -14.5% | PS3.7x | |
A Agilent Technologies | US$142.92 | 1.5% +US$589.4m | 17.2% | PE29.1x |